ArticleScientific reports2025
Retinal vessel segmentation using multi scale feature attention with MobileNetV2 encoder.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This work introduces the MSFAUMobileNet model, a complex U-Net structure tailored for retinal blood vessel segmentation, which is a critical process for detecting and monitoring retinal diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration (AMD). The model uses Multi-Scale Feature Aggregation (MSFA), Residual Connections, and Attention Mechanisms to enhance its segmentation accuracy. Utilizing MobileNetV2 as the encoder, the model is capable of effectively generating 13 bottleneck layers' worth of hierarchical features. Although residual connections and attention mechanisms are useful in improving the segmentation process and guaranteeing the precise outlining of intricate vascular networks, MSFA extracts spatial information at various resolutions. The model was tested on the DRIVE dataset and produced exceptionally high scores with accuracy at 99.99%, Dice coefficient at 99.95%, and Intersection over Union (IoU) at 99.94%. These scores show how efficiently the model separates the complex retinal network, enabling early treatment and detection of retinal disease. MSFAUMobileNet is a good medical image analysis software for real clinical practice owing to its computational speed and precision, particularly in the management of retinal disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.